A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 2, Pages 617
Publisher
MDPI AG
Online
2018-02-21
DOI
10.3390/ijms19020617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Metabolic profiling on the effect of 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47) in MCF-7 cells
- (2018) Juntong Wei et al. CHEMOSPHERE
- Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations
- (2017) Rokaya El Ansari et al. HISTOPATHOLOGY
- Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
- (2017) Robert Cornelison et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1 H HR-MAS NMR spectroscopy
- (2017) Roberta M. Maria et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy
- (2017) Leslie R. Euceda et al. Metabolomics
- Activation of the LKB1‑SIK1 signaling pathway inhibits the TGF‑β‑mediated epithelial‑mesenchymal transition and apoptosis resistance of ovarian carcinoma cells
- (2017) Bo Hong et al. Molecular Medicine Reports
- Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
- (2017) L Jin et al. ONCOGENE
- Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro
- (2017) Sabrina Nickel et al. PHARMACEUTICAL RESEARCH
- 1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients
- (2017) Aru Singh et al. PLoS One
- Neoadjuvant and Adjuvant Therapies for Breast Cancer
- (2017) Susmitha Apuri SOUTHERN MEDICAL JOURNAL
- The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance
- (2017) Mohammad Reza Sadeghi et al. TUMOR BIOLOGY
- Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model
- (2017) Yoriko Yamashita-Kashima et al. Oncology Letters
- Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
- (2017) Vincent Richard et al. Oncotarget
- Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study
- (2017) Liheng Zhou et al. Oncotarget
- Prognostic significance of HER3 in patients with malignant solid tumors
- (2017) Qin Li et al. Oncotarget
- A plasma metabolomic signature discloses human breast cancer
- (2017) Mariona Jové et al. Oncotarget
- Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry
- (2017) Naila Irum Hadi et al. Scientific Reports
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer
- (2016) Gaëlle Judes et al. CANCER LETTERS
- Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
- (2016) Shilpi Saha et al. CANCER RESEARCH
- Do platinum salts fit all triple negative breast cancers?
- (2016) L. Gerratana et al. CANCER TREATMENT REVIEWS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectives
- (2016) Catherine E Steding Future Oncology
- Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
- (2016) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences
- (2016) Delisha A. Stewart et al. JOURNAL OF PROTEOME RESEARCH
- Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
- (2016) Vidar G. Flote et al. Lipids in Health and Disease
- Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer
- (2016) Gianmaria Miolo et al. Oncotarget
- On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
- (2016) Judith Penkert et al. Oncotarget
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer
- (2015) Sung Yeon Park et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- International Variation in Female Breast Cancer Incidence and Mortality Rates
- (2015) C. E. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Biomarker assessment and molecular testing for prognostication in breast cancer
- (2015) Zuzana Kos et al. HISTOPATHOLOGY
- The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer
- (2015) Xu Wan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters
- (2015) Ibtissam Marchiq et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Emerging field of metabolomics: Big promise for cancer biomarker identification and drug discovery
- (2015) Seema Patel et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
- (2015) Jack JA van Asten et al. Journal of Translational Medicine
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- Dysregulated metabolism contributes to oncogenesis
- (2015) Matthew D. Hirschey et al. SEMINARS IN CANCER BIOLOGY
- Lowered circulating aspartate is a metabolic feature of human breast cancer
- (2015) Guoxiang Xie et al. Oncotarget
- Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System
- (2015) Takayuki Ueno et al. Biomed Research International
- Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24−/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
- (2014) MATEUSZ OPYRCHAL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Drug resistance to targeted therapies: Déjà vu all over again
- (2014) Floris H. Groenendijk et al. Molecular Oncology
- HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
- (2013) Allan Lipton et al. BREAST CANCER RESEARCH AND TREATMENT
- Rethinking the war on cancer
- (2013) Douglas Hanahan LANCET
- Functional Metabolomics Uncovers Metabolic Alterations Associated to Severe Oxidative Stress in MCF7 Breast Cancer Cells Exposed to Ascididemin
- (2013) Daniel Morvan Marine Drugs
- Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
- (2013) Bei Cao et al. Metabolomics
- Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel
- (2013) Mathilde Bayet-Robert et al. PLoS One
- Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse
- (2012) G. Cancello et al. ANNALS OF ONCOLOGY
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
- (2012) D H Morrison et al. BRITISH JOURNAL OF CANCER
- Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
- (2012) Laura J. Esserman et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer
- (2012) Siwei Wei et al. Molecular Oncology
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods
- (2012) Jian Zhang et al. PLoS One
- Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
- (2012) M. Jain et al. SCIENCE
- A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
- (2011) Yahong Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases
- (2011) B Chaiwun et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells
- (2011) Chang Seon Ryu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- DNA Damage-Mediated Induction of a Chemoresistant Niche
- (2010) Luke A. Gilbert et al. CELL
- Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer
- (2010) Amye J. Tevaarwerk et al. CLINICAL THERAPEUTICS
- HR MAS MR Spectroscopy in Metabolic Characterization of Cancer
- (2010) Siver Moestue et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Molecular Stratification of Triple-Negative Breast Cancers
- (2010) C. M. Perou ONCOLOGIST
- Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes
- (2010) Ian R. Lanza et al. PLoS One
- Mitochondrial Uncoupling and the Warburg Effect: Molecular Basis for the Reprogramming of Cancer Cell Metabolism
- (2009) I. Samudio et al. CANCER RESEARCH
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
- (2009) S. Germano et al. CURRENT CANCER DRUG TARGETS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Metabolomics-based methods for early disease diagnostics
- (2008) GA Nagana Gowda et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation